BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 1887523)

  • 21. Comparison of fibronectin content in urinary macromolecules between normal subjects and recurrent stone formers.
    Tsujihata M; Miyake O; Yoshimura K; Kakimoto K; Takahara S; Okuyama A
    Eur Urol; 2001 Oct; 40(4):458-62. PubMed ID: 11713403
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Urinary saturation and risk factors for calcium oxalate stone disease based on spot and 24-hour urine specimens.
    Ogawa Y; Yonou H; Hokama S; Oda M; Morozumi M; Sugaya K
    Front Biosci; 2003 Sep; 8():a167-76. PubMed ID: 12957883
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Determination of the calcium oxalate crystallization risk from urine samples: the BONN Risk Index in comparison to other risk formulas.
    Laube N; Hergarten S; Hoppe B; Schmidt M; Hesse A
    J Urol; 2004 Jul; 172(1):355-9. PubMed ID: 15201810
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Urinary glycosaminoglycans are selectively included into calcium oxalate crystals precipitated from whole human urine.
    Suzuki K; Mayne K; Doyle IR; Ryall RL
    Scanning Microsc; 1994; 8(3):523-30. PubMed ID: 7747154
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Studies on calcium oxalate crystal formation in urolithiasis. Multi-regressive analysis of urinary CaOx crystalline volumes and the effects of urinary various substances on CaOx crystal formation].
    Kataoka K; Umekawa T; Katayama Y; Ishikawa Y; Kodama M; Takamura C; Takada M; Kato Y; Hohri K; Iguchi M
    Nihon Hinyokika Gakkai Zasshi; 1991 May; 82(5):799-803. PubMed ID: 1875573
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Potential role of fluctuations in the composition of renal tubular fluid through the nephron in the initiation of Randall's plugs and calcium oxalate crystalluria in a computer model of renal function.
    Robertson WG
    Urolithiasis; 2015 Jan; 43 Suppl 1():93-107. PubMed ID: 25407799
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of ascorbic acid consumption on urinary stone risk factors.
    Traxer O; Huet B; Poindexter J; Pak CY; Pearle MS
    J Urol; 2003 Aug; 170(2 Pt 1):397-401. PubMed ID: 12853784
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibitory effect of bikunin on calcium oxalate crystallization in vitro and urinary bikunin decrease in renal stone formers.
    Médétognon-Benissan J; Tardivel S; Hennequin C; Daudon M; Drüeke T; Lacour B
    Urol Res; 1999; 27(1):69-75. PubMed ID: 10092156
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Separate effects of urinary chondroitin sulphate and heparan sulphate on the crystallization of urinary calcium oxalate: differences between stone formers and normal control subjects.
    Shum DK; Gohel MD
    Clin Sci (Lond); 1993 Jul; 85(1):33-9. PubMed ID: 8149691
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhibition of calcium oxalate crystallization in urine.
    Tiselius HG; Fornander AM; Nilsson MA
    Urol Res; 1987; 15(2):83-6. PubMed ID: 3590434
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Is citrate an inhibitor of calcium oxalate crystal growth in high concentrations of urine?
    Bek-Jensen H; Fornander AM; Nilsson MA; Tiselius HG
    Urol Res; 1996; 24(2):67-71. PubMed ID: 8740974
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Uric acid-binding proteins in calcium oxalate stone formers and their effect on calcium oxalate crystallization.
    Kalaiselvi P; Udayapriya KL; Selvam R
    BJU Int; 1999 Jun; 83(9):919-23. PubMed ID: 10368229
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A new approach to calculate the risk of calcium oxalate crystallization from unprepared native urine.
    Laube N; Schneider A; Hesse A
    Urol Res; 2000 Aug; 28(4):274-80. PubMed ID: 11011968
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Does urine from stone-formers contain macromolecules which promote the crystal growth rate of calcium oxalate crystals in vitro?
    Gjaldbaek JC; Robertson WG
    Clin Chim Acta; 1980 Nov; 108(1):75-80. PubMed ID: 6778638
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The alteration of urine composition due to stone material present in the urinary tract.
    Laube N; Pullmann M; Hergarten S; Schmidt M; Hesse A
    Eur Urol; 2003 Nov; 44(5):595-9. PubMed ID: 14572760
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical validation of urinary indole-reacted calcium oxalate crystallization index (iCOCI) test for diagnosing calcium oxalate urolithiasis.
    More-Krong P; Tubsaeng P; Madared N; Srisa-Art M; Insin N; Leeladee P; Boonla C
    Sci Rep; 2020 May; 10(1):8334. PubMed ID: 32433482
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Calcium oxalate crystallization in undiluted postprandial urine of healthy male volunteers as influenced by citrate.
    Fan J; Schwille PO; Schmiedl A; Fink E; Manoharan M
    Arzneimittelforschung; 2001 Oct; 51(10):848-57. PubMed ID: 11715639
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of urine dilution on quantity, size and aggregation of calcium oxalate crystals induced in vitro by an oxalate load.
    Guerra A; Allegri F; Meschi T; Adorni G; Prati B; Nouvenne A; Novarini A; Maggiore U; Fiaccadori E; Borghi L
    Clin Chem Lab Med; 2005; 43(6):585-9. PubMed ID: 16006253
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Determination of GOT activity on nucleation and crystal growth of calcium oxalate.
    Azoury R; Sarig S; Garti N; Perlberg S; Randolph AD; Drach GW
    Urol Res; 1984; 12(4):223-6. PubMed ID: 6149642
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of urinary macromolecules on the crystallization of calcium oxalate.
    Tiselius HG; Fornander AM; Nilsson MA
    Urol Res; 1990; 18(6):381-5. PubMed ID: 2100412
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.